Biophysical Analysis of Therapeutic Antibodies in the Early Development Pipeline
Open Access
- 1 December 2024
- journal article
- research article
- Published by Taylor & Francis in Biologics: Targets and Therapy
- Vol. ume 18, 413-432
Abstract
The successful progression of therapeutic antibodies and other biologics from the laboratory to the clinic depends on their possession of "drug-like" biophysical properties. The techniques and the resultant biophysical and biochemical parameters used to characterize their ease of manufacture can be broadly defined as developability. Focusing on antibodies, this review firstly discusses established and emerging biophysical techniques used to probe the early-stage developability of biologics, aimed towards those new to the field. Secondly, we describe the inter-relationships and redundancies amongst developability assays and how in silico methods aid the efficient deployment of developability to bring a new generation of cost-effective therapeutic proteins from bench to bedside more quickly and sustainably.Keywords
This publication has 248 references indexed in Scilit:
- Machine learning and statistical analyses for extracting and characterizing “fingerprints” of antibody aggregation at container interfaces from flow microscopy imagesBiotechnology and Bioengineering, 2020
- The uniqueness of flow in probing the aggregation behavior of clinically relevant antibodiesEngineering Reports, 2020
- Synergistic effects of flow and interfaces on antibody aggregationBiotechnology and Bioengineering, 2019
- Using extensional flow to reveal diverse aggregation landscapes for three IgG1 moleculesBiotechnology and Bioengineering, 2018
- Global and Local Conformation of Human IgG Antibody Variants Rationalizes Loss of Thermodynamic StabilityAngewandte Chemie International Edition, 2015
- A multiscale view of therapeutic protein aggregation: A colloid science perspectiveBiotechnology Journal, 2015
- Protein misfolding and aggregation research: Some thoughts on improving quality and utilityBiotechnology Progress, 2013
- Physical degradation of proteins in well‐defined fluid flows studied within a four‐roll apparatusBiotechnology and Bioengineering, 2011
- Factors influencing antibody stability at solid–liquid interfaces in a high shear environmentBiotechnology Progress, 2009
- Shaken, Not Stirred: Mechanical Stress Testing of an IgG1 AntibodyJournal of Pharmaceutical Sciences, 2008